Steroid administration in the setting of acute spinal cord injury (SCI) became popularized through the 1990's largely as a consequence of the National Acute Spinal Cord Injury Studies (NASCIS) II and III studies, each published in two segments of 6 and 12 month follow-up respectively. [1][2][3][4] However, as health care institutions created and revised protocols for methylprednisolone administration, controversy arose when a number of authors published independent interpretations of the available NASCIS II and III data disputing the conclusions of the NASCIS authors. [5][6][7][8][9] Most criticism questioned claimed statistical significance from arbitrary post-hoc analyses in the absence of clear clinical relevance. Issues were also raised with respect to ABSTRACT: Objective: To re-evaluate practice patterns for methylprednisolone (MP) administration in patients with acute spinal cord injury (SCI) within the spinal surgery community across Canada five years after the publication of practice recommendations. Methods: Canadian orthopedic and neurological spine surgeons were surveyed at their respective annual meetings about their practice of steroid administration for acute SCI by means of a questionnaire comprised of the same seven questions posed five years ago plus an additional question related to change of view. Results: Forty-two surgeons and twenty-one residents directly involved in the acute management of SCI completed the questionnaire. Seventy-six percent of spinal surgeons do not prescribe MP for SCI in sharp contrast to 76% who prescribed it five years ago. Of the 24% who use steroids, the NASCIS II dosing regimen is most commonly followed. One third of physicians continue to administer MP because of fear of litigation. Conclusions: Over a five year period there has been a complete reversal in practice patterns of MP administration for SCI, along with an increased familiarity of the published literature. Attendance at meetings, participation in local group discussions, and peer-reviewed publications appear effective in altering practice preferences arising from peer pressure and even fear of litigation.
RÉSUMÉ: La méthylprednisolone dans le traumatisme aigu de la moelle épinière : changement des habitudes de prescription depuis 5 ans.Objectif : L'objectif était de réévaluer les habitudes de pratique des chirurgiens canadiens depuis la publication des recommandations de bonne pratique concernant l'administration de la methylprednisolone (MP) chez les patients qui ont subi une lésion traumatique de la moelle épinière (LTMÉ). Méthodes : Il s'agit d'une enquête effectuée auprès des orthopédistes et des neurochirurgiens lors de leur congrès annuel respectif sur leurs habitudes de prescription de stéroïdes chez les patients qui ont subi une LTMÉ. Le questionnaire comportait sept questions identiques à celles posées il y a cinq ans et une question additionnelle sur le changement d'opinion. Résultats : Quarante-deux chirurgiens et vingt et un résidants directement impliqués dans le traitement de la LTMÉ en ph...